1 – 10 of 29
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Inhibition of oxidized low-density lipoprotein with orticumab inhibits coronary inflammation and reduces residual inflammatory risk in psoriasis: a pilot randomized, double-blind placebo-controlled trial
2024) In Cardiovascular Research(
- Contribution to journal › Article
- 2021
-
Mark
Promoting athero-protective immunity by vaccination with low density lipoprotein-derived antigens
(
- Contribution to journal › Scientific review
-
Mark
Association of Epicardial Fat Volume With the Extent of Coronary Atherosclerosis and Cardiovascular Adverse Events in Asymptomatic Patients With Diabetes
(
- Contribution to journal › Article
- 2014
-
Mark
Vaccine for Atherosclerosis.
(
- Contribution to journal › Scientific review
- 2013
-
Mark
Vaccines against atherosclerosis.
(
- Contribution to journal › Scientific review
- 2012
-
Mark
High levels of IgM against methylglyoxal-modified apolipoprotein B100 is associated with less coronary artery calcification in patients with type 2 diabetes.
(
- Contribution to journal › Article
- 2009
-
Mark
Regulatory T cells and the control of modified lipoprotein autoimmunity-driven atherosclerosis.
(
- Contribution to journal › Article
- 2008
-
Mark
Athero-protective effects of a human apoB-100 related peptide vaccine in apoE-/- mice are modulated by peptide dose and time of initiation of high fat diet
2008) American College of Cardiology 57th Annual Scientific Session In Journal of the American College of Cardiology 51(10, Suppl. 1). p.343-343(
- Contribution to journal › Published meeting abstract
- 2007
-
Mark
Active and passive immunization for atherosclerosis
(
- Contribution to journal › Scientific review
-
Mark
Immunization for atherosclerosis
(
- Contribution to journal › Scientific review